CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results and Announces Nadim Yared Retirement Plans
08. Januar 2024 08:30 ET
|
CVRx, Inc.
Fourth quarter revenue expected to be $11.2 million to $11.3 million, representing growth of 56% to 58%Full year revenue expected to be $39.2 million to $39.3 million, representing growth of 74% to...
CVRx to Present at the 42nd Annual J.P. Morgan Healthcare Conference
27. Dezember 2023 16:30 ET
|
CVRx, Inc.
MINNEAPOLIS, Dec. 27, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
CVRx receives FDA approval for expanded labeling of Barostim
26. Dezember 2023 08:05 ET
|
CVRx, Inc.
MINNEAPOLIS, Dec. 26, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that the U.S. Food and Drug Administration (FDA) has...
CVRx to Present at the 35th Annual Piper Sandler Healthcare Conference
15. November 2023 16:21 ET
|
CVRx, Inc.
MINNEAPOLIS, Nov. 15, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative...
CMS Increases Outpatient Payment for Barostim Procedure
03. November 2023 08:00 ET
|
CVRx, Inc.
MINNEAPOLIS, Nov. 03, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that Centers for Medicare and Medicaid Services (CMS)...
CVRx Reports Third Quarter 2023 Financial and Operating Results
26. Oktober 2023 16:15 ET
|
CVRx, Inc.
MINNEAPOLIS, Oct. 26, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative...
CVRx to Report Third Quarter 2023 Financial and Operating Results and Host Conference Call on October 26th, 2023
12. Oktober 2023 16:30 ET
|
CVRx, Inc.
MINNEAPOLIS, Oct. 12, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an...
CVRx to Present at the Canaccord Genuity 43rd Annual Growth Conference
27. Juli 2023 08:30 ET
|
CVRx, Inc.
MINNEAPOLIS, July 27, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative...
CVRx Reports Second Quarter 2023 Financial and Operating Results
25. Juli 2023 16:15 ET
|
CVRx, Inc.
MINNEAPOLIS, July 25, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative...
CVRx to Report Second Quarter 2023 Financial and Operating Results and Host Conference Call on July 25th, 2023
11. Juli 2023 16:30 ET
|
CVRx, Inc.
MINNEAPOLIS, July 11, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an...